Literature DB >> 9920935

Regulation of fibroblast motility by the protein tyrosine phosphatase PTP-PEST.

A J Garton1, N K Tonks.   

Abstract

The protein tyrosine phosphatase PTP-PEST is a cytosolic enzyme that displays a remarkable degree of selectivity for tyrosine-phosphorylated p130(Cas) as a substrate, both in vitro and in intact cells. We have investigated the physiological role of PTP-PEST using Rat1 fibroblast-derived stable cell lines that we have engineered to overexpress PTP-PEST. These cell lines exhibit normal levels of tyrosine phosphorylation of the majority of proteins but have significantly lower levels of tyrosine phosphorylation of p130(Cas) than control cells. Initial cellular events occurring following integrin-mediated attachment to fibronectin (cell attachment and spreading) are essentially unchanged in cells overexpressing PTP-PEST; similarly, the extent and time course of mitogen-activated protein kinase activation in response to integrin engagement is unchanged. In contrast, the reduced phosphorylation state of p130(Cas) is associated with a considerably reduced rate of cell migration and a failure of cells overexpressing PTP-PEST to accomplish the normally observed redistribution of p130(Cas) to the leading edge of migrating cells. Furthermore, cells overexpressing PTP-PEST demonstrate significantly reduced levels of association of p130(Cas) with the Crk adaptor protein. Our results suggest that one physiological role of PTP-PEST is to dephosphorylate p130(Cas), thereby controlling tyrosine phosphorylation-dependent signaling events downstream of p130(Cas) and regulating cell migration.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9920935     DOI: 10.1074/jbc.274.6.3811

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  31 in total

1.  PTP-PEST, a scaffold protein tyrosine phosphatase, negatively regulates lymphocyte activation by targeting a unique set of substrates.

Authors:  D Davidson; A Veillette
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Epidermal growth factor-induced tumor cell invasion and metastasis initiated by dephosphorylation and downregulation of focal adhesion kinase.

Authors:  Z Lu; G Jiang; P Blume-Jensen; T Hunter
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 3.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

4.  PTP-PEST couples membrane protrusion and tail retraction via VAV2 and p190RhoGAP.

Authors:  Sarita K Sastry; Zenon Rajfur; Betty P Liu; Jean-Francois Cote; Michel L Tremblay; Keith Burridge
Journal:  J Biol Chem       Date:  2006-03-02       Impact factor: 5.157

5.  PTPN12 controls PTEN and the AKT signalling to FAK and HER2 in migrating ovarian cancer cells.

Authors:  Emma Villa-Moruzzi
Journal:  Mol Cell Biochem       Date:  2012-12-02       Impact factor: 3.396

Review 6.  The role of Nox-mediated oxidation in the regulation of cytoskeletal dynamics.

Authors:  Alejandra Valdivia; Charity Duran; Alejandra San Martin
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

7.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

8.  Macrophage fusion is controlled by the cytoplasmic protein tyrosine phosphatase PTP-PEST/PTPN12.

Authors:  Inmoo Rhee; Dominique Davidson; Cleiton Martins Souza; Jean Vacher; André Veillette
Journal:  Mol Cell Biol       Date:  2013-04-15       Impact factor: 4.272

Review 9.  CAS proteins in normal and pathological cell growth control.

Authors:  Nadezhda Tikhmyanova; Joy L Little; Erica A Golemis
Journal:  Cell Mol Life Sci       Date:  2009-11-25       Impact factor: 9.261

10.  Protein tyrosine phosphatases expression during development of mouse superior colliculus.

Authors:  Jacqueline Reinhard; Andrea Horvat-Bröcker; Sebastian Illes; Angelika Zaremba; Piotr Knyazev; Axel Ullrich; Andreas Faissner
Journal:  Exp Brain Res       Date:  2009-09-01       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.